Evidence map›Paper›PMID 27091453›Full record

ArticleAge (Dordrecht, Netherlands)2016

Bisulfite oligonucleotide-capture sequencing for targeted base- and strand-specific absolute 5-methylcytosine quantitation.

Dustin R Masser, David R Stanford, Niran Hadad, Cory B Giles, Jonathan D Wren, William E Sonntag, Arlan Richardson, Willard M Freeman

Abstract read
In one paragraph

Article in Age (Dordrecht, Netherlands), 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Latest techniques to study DNA methylation.Essays in biochemistry · 2019
    Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Dustin R MasserDepartment of Physiology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.
David R StanfordDepartment of Physiology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.
Niran HadadReynolds Oklahoma Center on Aging, Oklahoma City, OK, USA.
Cory B GilesArthritis and Clinical Immunology Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, USA.
Jonathan D WrenReynolds Oklahoma Center on Aging, Oklahoma City, OK, USA.
William E SonntagDepartment of Physiology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.
Arlan RichardsonDepartment of Physiology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.
Willard M FreemanDepartment of Physiology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA. wfreeman@ouhsc.edu.

Funding

Targeted DNA Methylation and Mitochondrial Heteroplasmy CoreP30AG050911 · NIA · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI Matthew John Hart · 2015 to 2026
$13.9M
NOVEL APPROACHES FOR REGULATION OF IGF-1 LEVELS THROUGHOUT THE LIFESPANR01AG038747 · NIA · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI SONNTAG, WILLIAM EDMUND · 2011 to 2015
$2.4M
Cognitive Decline & Protein Expression Profiles in AgingR01AG026607 · NIA · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI SONNTAG, WILLIAM EDMUND · 2007 to 2011
$1.8M
INSULIN-THERAPY RESISTANT EPIGENETIC MODIFICATIONS IN DIABETIC RETINOPATHYR01EY021716 · NEI · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI FREEMAN, WILLARD M · 2011 to 2014
$1.3M
Vision Science Training ProgramT32EY023202 · NEI · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI CALLEGAN, MICHELLE C · 2014 to 2025
$952k
Gene Promoter DNA Methylation with Cocaine Self-Administration and AbstinenceR21DA029405 · NIDA · PENNSYLVANIA STATE UNIV HERSHEY MED CTR · PI FREEMAN, WILLARD M · 2010 to 2011
$387k
NEI NIH HHS R01 EY021716NEI NIH HHS R01EY021716NEI NIH HHS T32 EY023202NEI NIH HHS T32EY023202NIA NIH HHS P30 AG050911NIA NIH HHS P30AG050911NIA NIH HHS R01 AG026607NIA NIH HHS R01AG026607NIA NIH HHS R01 AG038747NIDA NIH HHS R21 DA029405NIDA NIH HHS R21DA029405
6 · The paper itself

Abstract

Epigenetic regulation through DNA methylation (5mC) plays an important role in development, aging, and a variety of diseases. Genome-wide studies of base- and strand-specific 5mC are limited by the extensive sequencing required. Targeting bisulfite sequencing to specific genomic regions through sequence capture with complimentary oligonucleotide probes retains the advantages of bisulfite sequencing while focusing sequencing reads on regions of interest, enables analysis of more samples by decreasing the amount of sequence required per sample, and provides base- and strand-specific absolute quantitation of CG and non-CG methylation levels. As an example, an oligonucleotide capture set to interrogate 5mC levels in all rat RefSeq gene promoter regions (18,814) and CG islands, shores, and shelves (18,411) was generated. Validation using whole-genome methylation standards and biological samples demonstrates enrichment of the targeted regions and accurate base-specific quantitation of CG and non-CG methylation for both forward and reverse genomic strands. A total of 170 Mb of the rat genome is covered including 6.6 million CGs and over 67 million non-CG sites, while reducing the amount of sequencing required by ~85 % as compared to existing whole-genome sequencing methods. This oligonucleotide capture targeting approach and quantitative validation workflow can also be applied to any genome of interest.

Indexed as

5-MethylcytosineAgingAnimalsDNADNA MethylationEpigenesis, GeneticRatsSequence Analysis, DNASulfites5-MethylcytosineDNAhydrogen sulfiteSulfitesBisulfite sequencingDNA methylationRat

Identifiers

PMID27091453
PMCPMC5005917

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.